Biomarin Pharmaceutical (BMRN) Q4 2025 Earnings

Oct 27Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.28
0.22
0.73
1.23

Details

Expected EPS
-0.280081
Actual EPS
-0.16
Surprise EPS
0.12
Surprise Percent
+42.87%

Description

⁨Biomarin Pharmaceutical⁩ (⁦BMRN⁩) has reported earnings of ⁦-0.16⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts